首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

南美洲和中美洲臨床試驗市場預測至 2028 年 - 區域分析 - 按研究設計、階段和適應症

市場調查報告書

商品編碼

1402478

南美洲和中美洲臨床試驗市場預測至 2028 年 - 區域分析 - 按研究設計、階段和適應症

South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design, Phase, and Indication

出版日期: 2023年10月26日 | 出版商:

The Insight Partners | 英文 125 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

南美洲和中美洲臨床試驗市場預計將從2022年的17.9469億美元成長到2028年的25.2398億美元。預計2022年至2028年CAGR為5.8%。

分散臨床試驗和混合臨床試驗的採用推動了南美洲和中美洲臨床試驗市場

在分散臨床試驗 (DCT) 中，患者實際進入醫院試驗地點的機會被減少或消除。在 DCT 中，數位技術用於使患者能夠參與臨床研究、遠端資料收集和監測以及研究人員和參與者之間的溝通。混合臨床試驗方法結合了家庭和現場活動，帶來最佳的患者體驗並滿足複雜的方案製度，在各個治療領域和試驗階段旅程中獲得吸引力。最初，由於病患隱私、資料安全、監管障礙和複雜的協議制度等挑戰，DCT的採用受到了影響。然而，由於COVID-19大流行，臨床試驗的申辦者採用了分散和混合的臨床技術來開發藥物。他們無法繼續進行傳統試驗，因為需要親自拜訪。由於旅行的限制，收集資料和繼續試驗的唯一方法是遠端工作並比其他方式更快地採用技術。因此，權力下放擴大了試驗範圍，以涵蓋更多數量且可能更多樣化的患者群體。

此外，混合臨床試驗允許申辦者策略性地將分散臨床試驗（DCT）元素涵蓋研究設計中。這些試驗模型提供了前所未有的靈活性，因此更多的公司對混合試驗感興趣，由此產生的成長正在重新定義產業格局。據 ObvioHealth 稱，FDA 計劃在 2023 年推出支持 DCT 方法使用的方案，激發人們對這些成分用於未來臨床研究的信心。因此，與傳統臨床試驗方法相比，對使用分散和混合臨床試驗的日益關注預計將在預測期內為臨床試驗市場提供利潤豐厚的機會。

南美洲和中美洲臨床試驗市場概述

南美洲和中美洲臨床試驗市場分為巴西、阿根廷以及南美洲和中美洲其他地區。南美洲和中美洲在臨床試驗市場中佔據重要地位，預計在預測期內將出現強勁的成長率。這一成長是由於臨床試驗的不斷成長、臨床試驗流程市場參與者的關鍵創新以及政府支持臨床試驗的舉措推動了市場的成長。

南美洲和中美洲臨床試驗市場收入及 2028 年預測（百萬美元）

南美洲和中美洲臨床試驗市場細分

南美洲和中美洲臨床試驗市場分為階段、研究設計、適應症和國家。

根據階段，南美洲和中美洲臨床試驗市場分為 I 期、II 期、III 期和 IV 期。 2022 年，III 期細分市場在南美洲和中美洲臨床試驗市場佔有率最大。

根據研究設計，南美洲和中美洲臨床試驗市場分為介入性、觀察性和擴大訪問。 2022 年，介入性細分市場佔據南美洲和中美洲最大的臨床試驗市場。

根據適應症，南美洲和中美洲臨床試驗市場分為自體免疫/發炎、疼痛管理、腫瘤、中樞神經系統疾病、糖尿病、肥胖、心血管等。 2022 年，腫瘤學領域佔據南美洲和中美洲最大的臨床試驗市場。

根據國家/地區，南美洲和中美洲臨床試驗市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年，南美洲和中美洲其他地區主導了南美洲和中美洲臨床試驗市場佔有率。

Charles River Laboratories International Inc、ICON Plc、IQVIA Holdings Inc、Laboratory Corp of America Holdings、Parexel International Corp、SGS SA、Syneos Health Inc 和 Thermo Fisher Scientific Inc. 是在南美洲和中美洲臨床營運的一些領先公司試銷市場。

In decentralized clinical trials (DCT), patients' physical access to hospital-based trial sites is reduced or eliminated. In DCTs, digital technologies are used to enable access of patients to clinical research, remote data collection and monitoring, and communication between investigators and participants. A hybrid clinical trial approach combines home-based and on-site activities, bringing the best patient experience and meeting complex protocol regimes, gaining traction across various therapeutic areas and trial phase journeys. Initially, due to challenges such as patient privacy, data security, regulatory barriers, and complex protocol regimes, the adoption of DCT was affected. However, due to the COVID-19 pandemic, the sponsors of clinical trials adopted decentralized and hybrid clinical techniques for developing drugs. They could not continue with traditional trials as they required in-person visits. Due to the restrictions for travel, the only way to gather data and keep trials going was to work remotely and adopt technology much faster than they would have otherwise. Therefore, decentralization broadens trial access to reach a larger number and potentially a more diverse pool of patients.

Further, hybrid clinical trials allow sponsors to strategically incorporate decentralized clinical trial (DCT) elements into study designs. These trial models offer unprecedented flexibility, so more companies are interested in hybrid trials, and the resulting growth is redefining the industry landscape. According to ObvioHealth, the FDA plans to unveil protocols in 2023 to support the use of DCT methods, inspiring confidence in these components for future clinical research. Thus, the increasing focus on using decentralized and hybrid clinical trials over traditional clinical trial methods is expected to provide lucrative opportunities for the clinical trials market during the forecast period.

South & Central America Clinical Trials Market Overview

The South & Central America clinical trials market is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America occupies a significant position in the clinical trials market and is estimated to register a robust growth rate over the forecast period. The growth is due to growing clinical trials, key innovation by market players of clinical trial process, and government initiatives to support the clinical trial fuels the market growth.

South & Central America Clinical Trials Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Clinical Trials Market Segmentation

The South & Central America clinical trials market is segmented into phase, study design, indication, and country.

Based on phase, the South & Central America clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest South & Central America clinical trials market share in 2022.

Based on study design, the South & Central America clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest South & Central America clinical trials market share in 2022.

Based on indication, the South & Central America clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest South & Central America clinical trials market share in 2022.

Based on country, the South & Central America clinical trials market has been categorized into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America clinical trials market share in 2022.

Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the South & Central America clinical trials market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America clinical trials market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America clinical trials market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the clinical trials market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Clinical Trials Market - By Phase
- 1.3.2 South & Central America Clinical Trials Market - By Study Design
- 1.3.3 South & Central America Clinical Trials Market - By Indication
- 1.3.4 South & Central America Clinical Trials Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Clinical Trials Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 South And Central America PEST Analysis
4.3 Experts Opinion

5. South & Central America Clinical Trials Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
- 5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
- 5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. Clinical Trials Market - South & Central America Analysis

6.1 South & Central America Clinical Trials Market Revenue Forecast and Analysis

7. South & Central America Clinical Trials Market Revenue and Forecast To 2028 - by Study Design

7.1 Overview
7.2 South & Central America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
- 7.3.1 Overview
- 7.3.2 Interventional: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
- 7.4.1 Overview
- 7.4.2 Observational: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
- 7.5.1 Overview
- 7.5.2 Expanded Access: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Clinical Trials Market - By Phase

8.1 Overview
8.2 South & Central America Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
- 8.3.1 Overview
- 8.3.2 Phase III: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
- 8.4.1 Overview
- 8.4.2 Phase II: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
- 8.5.1 Overview
- 8.5.2 Phase IV: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
- 8.6.1 Overview
- 8.6.2 Phase I: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Clinical Trials Market Revenue and Forecast To 2028 - Indication

9.1 Overview
9.2 South & Central America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
- 9.3.1 Overview
- 9.3.2 Autoimmune/Inflammation: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
- 9.4.1 Overview
- 9.4.2 Pain Management: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
- 9.6.1 Overview
- 9.6.2 CNS Condition: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
- 9.7.1 Overview
- 9.7.2 Diabetes: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
- 9.8.1 Overview
- 9.8.2 Obesity: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
- 9.9.1 Overview
- 9.9.2 Cardiovascular: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
- 9.10.1 Overview
- 9.10.2 Other: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis

10.1 South & Central America Clinical Trials Market
- 10.1.1 Overview
- 10.1.2 South & Central America: Clinical Trials Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 Brazil: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Brazil: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 Brazil: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.1.4 Brazil: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.1.5 Brazil: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.2 Argentina: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Argentina: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Argentina: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.2.4 Argentina: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.2.5 Argentina: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.3 Rest of South & Central America: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Rest of South & Central America: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 Rest of South & Central America: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.3.4 Rest of South & Central America: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.3.5 Rest of South & Central America: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 IQVIA Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Parexel International Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Charles River Laboratories International Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 ICON Plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 SGS SA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Syneos Health Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Thermo Fisher Scientific Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6
- 12.7.7 Key Developments
12.8 Laboratory Corp of America Holdings
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Brazil Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 4. Argentina Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 7. Rest of South & Central America Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 8. Rest of South & Central America Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 9. Rest of South & Central America Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms

List Of Figures

Figure 1. South & Central America Clinical Trials Market Segmentation
Figure 2. South & Central America Clinical Trials Market, By Region
Figure 3. South & Central America Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in South & Central America Clinical Trials Market
Figure 5. Argentina is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South And Central America: PEST Analysis
Figure 7. South & Central America Experts Opinion
Figure 8. Impact Analysis
Figure 9. South & Central America Clinical Trials Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. South & Central America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. South & Central America Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. South & Central America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. South & Central America: Clinical Trials Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. South & Central America: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. Brazil: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Argentina: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of South & Central America: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Growth Strategies Done by the Companies in the Market, (%)